glp 1 ophthalmology The Impact of GLP-1 Receptor Agonists on Ocular Disease GLP-1s and Rapid Facial Aging:

Semaglutide is the active ingredient in Ozempic (FDA-approved for type 2 diabetes) and Wegovy (FDA-approved for chronic weight management)

This upward trend is largely driven by the aging population and the increasing incidence of risk factors like diabetes and hypertension (Rovin et al., 2024

Bariatric Surgery for long term durable results that is more cost effective than medication regimen

Conversely, many celiac patients gain excessive weight after starting a gluten-free diet due to improved absorption and the higher caloric density of many gluten-free products, making tirzepatide potentially beneficial for weight management in this subset, provided they meet the BMI criteria (30 kg/m or 27 kg/m with a weight-related comorbidity)